Strata Critical Medical, Inc.
NASDAQ:SRTAAirlines, Airports & Air Services
Industrials
$4.96 -0.43%
-$0.03 today
- Market cap
- $443.03M
- Beta
- 2.20
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.60
52W Low $3.57High $6.50
Volume 0.99M
Average 0.91M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$48.91M
FY 2025 · Annual
Investing Cash Flow
$69.75M
FY 2025 · Annual
Financing Cash Flow
-$8.91M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Sep 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (40.05M) | (27.26M) | (56.08M) | (27.31M) | 41.35M |
| Depreciation & Amortization | 596K | 5.73M | 7.11M | 5.96M | 8.19M |
| Deferred Income Tax | (3.64M) | (772K) | (1.47M) | (255K) | 432K |
| Stock-Based Compensation | 9.62M | 8.28M | 12.5M | 19.89M | 17.83M |
| Change in Working Capital | (2.2M) | (17K) | (6.74M) | (3.01M) | (9.08M) |
| Accounts Receivables | (414K) | (5.35M) | (10.25M) | (998K) | (12.03M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 9.9M | 0 | 0 | 0 |
| Other Working Capital | (1.79M) | (4.57M) | 3.52M | (2.01M) | 2.95M |
| Other Non-Cash Items | 20.06M | (23.08M) | 12.32M | 2.2M | (107.63M) |
| Operating Cash Flow | (15.62M) | (37.13M) | (32.35M) | (2.52M) | (48.91M) |
| Capital Expenditures | (801K) | (730K) | (2.11M) | (32.99M) | (11.01M) |
| Acquisitions (Net) | (23.07M) | (48.1M) | (39K) | (2.23M) | (69.35M) |
| Purchases of Investments | (308.77M) | (228.21M) | (265.97M) | (143.26M) | (146.26M) |
| Sales of Investments | 11.3M | 356.38M | 285.07M | 177.45M | 296.36M |
| Other Investing Activities | (504K) | 0 | 138K | (2.11M) | (1.42M) |
| Investing Cash Flow | (321.34M) | 79.34M | 17.09M | (1.02M) | 69.75M |
| Debt Repayment | (1.17M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 119.63M | 87K | 0 | 0 | 193K |
| Common Stock Repurchased | 0 | 0 | 0 | (244K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 213.79M | (1.17M) | (76K) | (5.52M) | (9.11M) |
| Financing Cash Flow | 332.26M | (1.08M) | (76K) | (5.76M) | (8.91M) |
| Effect of Forex Changes | 10.97M | (4.29M) | (66K) | (80K) | (339K) |
| Net Change in Cash | (4.69M) | 36.84M | (15.4M) | (9.37M) | 11.59M |
| Free Cash Flow | (16.42M) | (37.86M) | (34.46M) | (35.51M) | (59.92M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$41.3M
+ D&A$8.2M
+ Stock-Based Comp$17.8M
+ Deferred Tax$432.0K
- Working Capital-$9.1M
- Other Non-Cash-$107.6M
= Operating Cash Flow-$48.9M
- Capex-$11.0M
= Free Cash Flow-$59.9M
Analysis
FY2025 free cash flow is -$59.9M. FCF conversion is -144.9% of net income. Operating cash flow was -$48.9M, with capex of -$11.0M. The largest bridge item is Other Non-Cash at -$107.6M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 3, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| SC 13D | SC 13D filing | Oct 15, 2026 |
Does SRTA generate free cash flow?
Strata Critical Medical, Inc. (SRTA) generated -$59.92M of free cash flow in fiscal 2025.
How much operating cash flow does SRTA produce?
Operating cash flow was -$48.91M, before capital expenditures of $11.01M.
Continue the stock analysis
Jump to another research area for this company.